BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2477837)

  • 1. [Micrometastases of the axillary lymph nodes in breast cancer. An immunohistochemical study].
    Ronay G; Tomesch A; Tulusan AH
    Pathologe; 1989 Sep; 10(5):289-93. PubMed ID: 2477837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Micrometastases in axillary lymph nodes in breast cancer].
    Ronay G; Tomesch A; Tulusan AH
    Gynakol Rundsch; 1989; 29 Suppl 2():234-6. PubMed ID: 2558989
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lymph node metastasis of a "squamous cell carcinoma" as a manifestation of occult breast cancer].
    Ronay G; Zimmermann HD; Tulusan AH
    Pathologe; 1988 Sep; 9(5):309-12. PubMed ID: 2845387
    [No Abstract]   [Full Text] [Related]  

  • 4. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standards of pathohistologic processing of breast cancer. A contribution to quality assurance in pathology and patient care].
    Bässler R; Schnürch HG
    Gynakologe; 1994 Feb; 27(1):23-36. PubMed ID: 8168734
    [No Abstract]   [Full Text] [Related]  

  • 6. The pathologic profile of invasive breast cancer-ii) changes in the harboring mammary tissue and regional lymphnodes.
    Mehtani VG; Joshi K; Mehrotra GC
    Indian J Pathol Microbiol; 1987 Oct; 30(4):415-22. PubMed ID: 2853136
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary tumour characteristics and axillary lymph node status in breast cancer.
    Yiangou C; Shousha S; Sinnett HD
    Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical breast cancer diagnosis].
    Schauer A; Brehler R; Bergholz M
    Verh Dtsch Ges Pathol; 1985; 69():171-86. PubMed ID: 2420086
    [No Abstract]   [Full Text] [Related]  

  • 9. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
    Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC
    Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infiltrating lobular breast carcinoma: detection of occult regional lymph node metastasis by immunohistochemistry.
    Kainz C; Gitsch G; Lee A; Danihel L; Breitenecker G
    Anticancer Res; 1993; 13(1):73-4. PubMed ID: 7682802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcomatoid breast tumors have sarcomatoid behavior.
    Gilcrease MZ
    Am J Surg Pathol; 2007 Feb; 31(2):326-7; author reply 327. PubMed ID: 17255781
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
    Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G
    Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathology and classification of malignant breast tumors].
    Bässler R
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):973-80. PubMed ID: 1663676
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
    El-Tamer M; Chun J; Gill M; Bassi D; Lee S; Hibshoosh H; Mansukhani M
    Ann Surg Oncol; 2005 Mar; 12(3):254-9. PubMed ID: 15827818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphoreticular infiltrates in axillary lymph node metastases of invasive ductal breast cancers: histological and immunohistological findings].
    Horny HP; Horst HA
    Verh Dtsch Ges Pathol; 1985; 69():331-7. PubMed ID: 3006384
    [No Abstract]   [Full Text] [Related]  

  • 18. The significance of intraduct appearances in breast cancer.
    Cowen PN; Bates C
    Clin Oncol; 1984 Mar; 10(1):67-72. PubMed ID: 6323084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ arising in an epithelial inclusion within an axillary lymph node.
    Srinivasan B; Allan CP; Armes JE
    Pathology; 2007 Apr; 39(2):268-9. PubMed ID: 17454760
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
    Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
    Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.